ICD 2 Study

A prospective randomized controlled trial to evaluate the prevention of sudden cardiac death using implantable cardioverter defibrillators in dialysis patients. 

Aim of the study

Sudden cardiac death (SCD) is the single largest cause of death in dialysis patients. Implantable Cardioverter Defibrillator (ICD) has demonstrated to reduce the risk of SCD and all cause mortality in high risk patients. Whether ICD therapy benefits dialysis patients is unknown. We therefore designed a prospective randomized study to evaluate the primary prevention of SCD in dialysis patients. Furthermore we want to assess the predictive value of left ventricular hypertrophy and function, coronary artery calcification, vascular stiffness in determining cardiovascular events an especially SCD, using multi modality imaging.